Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

ANIK

Anika Therapeutics (ANIK)

Anika Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ANIK
일자시간출처헤드라인심볼기업
2024/05/0906:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIKAnika Therapeutics Inc
2024/05/0905:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
2024/05/0905:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
2024/05/0905:08GlobeNewswire Inc.Anika Announces CFO TransitionNASDAQ:ANIKAnika Therapeutics Inc
2024/05/0905:05GlobeNewswire Inc.Anika Reports First Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
2024/05/0405:01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
2024/04/1905:01GlobeNewswire Inc.Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024NASDAQ:ANIKAnika Therapeutics Inc
2024/04/0221:00GlobeNewswire Inc.Anika to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ANIKAnika Therapeutics Inc
2024/03/1405:05GlobeNewswire Inc.Anika Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
2024/03/1320:03IH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNASDAQ:ANIKAnika Therapeutics Inc
2024/03/0906:01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
2024/03/0709:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
2024/02/2806:01GlobeNewswire Inc.Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:ANIKAnika Therapeutics Inc
2024/02/2623:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
2024/02/1323:00GlobeNewswire Inc.Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual MeetingNASDAQ:ANIKAnika Therapeutics Inc
2024/02/1001:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
2024/01/2504:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
2024/01/2223:29Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ANIKAnika Therapeutics Inc
2024/01/2006:52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANIKAnika Therapeutics Inc
2024/01/1306:35Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
2023/11/2823:00GlobeNewswire Inc.Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market ReleaseNASDAQ:ANIKAnika Therapeutics Inc
2023/11/0806:05GlobeNewswire Inc.Anika to Participate in Upcoming Investor ConferencesNASDAQ:ANIKAnika Therapeutics Inc
2023/11/0305:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
2023/11/0305:05GlobeNewswire Inc.Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the BusinessNASDAQ:ANIKAnika Therapeutics Inc
2023/10/1022:00GlobeNewswire Inc.Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023NASDAQ:ANIKAnika Therapeutics Inc
2023/10/0405:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
2023/09/2120:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
2023/09/1922:00GlobeNewswire Inc.Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual MeetingNASDAQ:ANIKAnika Therapeutics Inc
2023/09/1605:01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
2023/09/1222:00GlobeNewswire Inc.Anika to Participate in the Sidoti Small Cap Virtual Investor ConferenceNASDAQ:ANIKAnika Therapeutics Inc
 검색 관련기사 보기:NASDAQ:ANIK